Please login to the form below

Not currently logged in
Email:
Password:

chronic diseases

This page shows the latest chronic diseases news and features for those working in and with pharma, biotech and healthcare.

Amgen raises forecasts after closing $13.4bn Otezla deal

Amgen raises forecasts after closing $13.4bn Otezla deal

As the prevalence of chronic inflammatory diseases increases worldwide, Otezla represents a unique opportunity to further Amgen's mission of bringing innovative medicines to patients, while building on our long-standing

Latest news

More from news
Approximately 2 fully matching, plus 171 partially matching documents found.

Latest Intelligence

  • The long and winding road to asthma breakthroughs The long and winding road to asthma breakthroughs

    Early research in biologics for respiratory diseases did not fare well, with disappointing clinical trials and a danger that the promise would run out of steam. ... It also voiced patient concern that asthma and Chronic Obstructive Pulmonary Disease were

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    Marking a new era in healthcare and one which has the promise of addressing the needs of an ageing population challenged by escalating chronic diseases, regenerative medicine is certainly a game ... Regenerative medicine is poised to transform healthcare

  • Rare disease trials Q&A Rare disease trials Q&A

    With 350 million people affected worldwide, rare diseases represent a major unmet medical need. ... Characterised by small, highly heterogeneous patient populations, including children in almost half of the cases, rare diseases are usually genetic and

  • Is anybody listening? Is anybody listening?

    Evidence shows that, in chronic disease areas, if you improve a patient’s knowledge, skills and confidence, those patients recover faster and live longer. ... The research says that online health communities have a major role to play in promoting

  • Innovation in merger control and the impact on the pharmaceutical sector Innovation in merger control and the impact on the pharmaceutical sector

    Specifically, Hospira was selling Inflectra, an infliximab biosimilar used to treat several chronic inflammatory diseases, notably the inflammation of Crohn’s disease, while Pfizer was in an advanced stage of developing

More from intelligence
Approximately 2 fully matching, plus 46 partially matching documents found.

Latest appointments

  • Kymab appoints its first chief medical officer Kymab appoints its first chief medical officer

    She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.

  • Dr Li Zhou joins TxCell as cell engineering VP Dr Li Zhou joins TxCell as cell engineering VP

    Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ

  • Sanofi’s US pharma head joins Synta as CEO Sanofi’s US pharma head joins Synta as CEO

    She now leads an emerging US-based biopharma focused on the development of small molecule drugs to treat patients with severe medical conditions, including cancer and chronic inflammatory diseases.

  • Medgenics confirms appointment of Dr Marvin Garovoy

    The company's Biopump uses a patient's own tissue to continuously produce and deliver their protein therapy and, potentially, has applications in a range of chronic diseases, including diabetes, multiple

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • WHITE PAPER: Patient nonadherence – the $637bn paradox WHITE PAPER: Patient nonadherence – the $637bn paradox

    In developed countries, adherence among patients suffering chronic diseases averages only 50%; levels in developing countries are thought to be considerably lower.[6] Given that nearly half of adults have a ... Multiple chronic conditions among US. adults

  • How Medisafe is using AI to improve patient adherence

    instructions. The World Health Organisation (WHO) estimates that by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide.

  • How Medisafe is using AI to improve patient adherence

    instructions. The World Health Organisation (WHO) estimates that by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide.

  • Irritable Bowel Syndrome (IBS) patient insights Irritable Bowel Syndrome (IBS) patient insights

    However, as is the case with many chronic diseases the extent to which the disease impacts upon a patient’s quality of life is inadequately represented by considering the symptoms alone. ... 2)  . "IBS is a chronic medical condition, although the

  • Wearables and healthcare Wearables and healthcare

    mid-twenties.[2]  . Factors such as these, among others, have increased the prevalence of chronic diseases, which account for around 70% of the health service budget.[3, 4] To ensure the ... The outputs of this process are predictive algorithms that

More from PMHub
Approximately 4 fully matching, plus 24 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics